MSD

Pembrolizumab

Biodrugs/ Drugs
Cancer
Pembrolizumab Plus Enzalutamide versus Placebo Plus Enzalutamide in Participants with metastatic Castration-Resistant Prostate Cancer
3Phase III in Spain, 2Phase II, 1Phase I